What is the current annual CAPEX of GSK?

As of today, GSK annual CAPEX is $3.93B

What is 1-year change in GSK annual CAPEX?

GSK annual CAPEX is up +3.24% year-over-year

What is 3-year change in GSK annual CAPEX?

GSK annual CAPEX is up +41.44% over the past 3 years

How far is GSK annual CAPEX from its all-time high?

GSK annual CAPEX is currently -8.27% below its historical high of $4.29B set on December 31, 2007

How does GSK annual CAPEX rank versus sector peers?

GSK annual CAPEX is higher than 99.38% of companies in Healthcare sector

When is GSK next annual earnings release?

The next annual earnings release for GSK is on February 3, 2027

What is the current quarterly CAPEX of GSK?

As of today, GSK quarterly CAPEX is $719.73M

What is GSK quarterly CAPEX most recent change?

GSK quarterly CAPEX was down -17.70% on September 30, 2026

What is 1-year change in GSK quarterly CAPEX?

GSK quarterly CAPEX is down -40.24% year-over-year

How far is GSK quarterly CAPEX from its all-time high?

GSK quarterly CAPEX is currently -56.95% below its historical high of $1.67B set on December 31, 2000

How does GSK quarterly CAPEX rank versus sector peers?

GSK quarterly CAPEX is higher than 99.13% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on February 3, 2027

What is the current TTM CAPEX of GSK?

As of today, GSK TTM CAPEX is $3.54B

What is GSK TTM CAPEX most recent change?

GSK TTM CAPEX was down -12.04% on September 30, 2026

What is 1-year change in GSK TTM CAPEX?

GSK TTM CAPEX is down -13.81% year-over-year

How far is GSK TTM CAPEX from its all-time high?

GSK TTM CAPEX is currently -17.79% below its historical high of $4.31B set on December 31, 2007

How does GSK TTM CAPEX rank versus sector peers?

GSK TTM CAPEX is higher than 99.42% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on February 3, 2027

GSK Plc (GSK) CAPEX History & Chart Since 1991

Annual CAPEX

$3.93B$123.47M+3.24%

December 31, 2025

Summary

Current Value: As of today, GSK annual CAPEX is $3.93B, up +3.24% on December 31, 2025
Historical Performance: GSK annual CAPEX is up +41.44% over the past 3 years, up +37.01% over the past 5 years
All-Time High Comparison: GSK annual CAPEX is currently -8.27% below its historical high of $4.29B set on December 31, 2007
3-Year Low Comparison: GSK annual CAPEX is +41.44% above its 3-year low of $2.78B reached on an earlier date
Sector Comparison: GSK annual CAPEX is higher than 99.38% of companies in Healthcare sector

CAPEX Chart

beforeafter

Performance

GSK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual CAPEX	Dec 31, 25	$3.93B	+3.2%	+41.4%	+37.0%	+55.9%
Quarterly CAPEX	Sep 30, 26	$719.73M	-40.2%	+12.2%	-56.8%	+53.9%
TTM CAPEX	Sep 30, 26	$3.54B	-13.8%	+25.5%	-12.5%	+68.6%
Price	Nov 6, 26	$50.33	+6.9%	+44.7%	+13.5%	+11.1%
Annual Cash From Operations	Dec 31, 25	$9.62B	+23.7%	+17.9%	-1.9%	+1.4%
Annual Free Cash Flow	Dec 31, 25	$5.69B	+43.2%	+5.8%	-17.9%	-18.3%
Annual Cash From Investing	Dec 31, 25	-$5.90B	-232.2%	+45.8%	-319.6%	-91.7%
Annual Total Assets	Dec 31, 25	$82.21B	+10.4%	+13.6%	-25.2%	+24.3%
Annual D&A	Dec 31, 25	$3.05B	-6.5%	+15.3%	+1.1%	+17.7%

CAPEX Highs

GSK Annual CAPEX Highs Comparison
Period	High	Date	Current
3Y	$3.93B	Dec 31, 25	at high
5Y	$3.93B	Dec 31, 25	at high
All	$4.29B	Dec 31, 07	-8.3%

CAPEX Lows

GSK Annual CAPEX Lows Comparison
Period	Low	Date	Current
3Y	$2.78B	N/A	+41.4%
5Y	$2.78B	Dec 31, 22	+41.4%
All	$625.63M	Dec 31, 96	+528.8%

CAPEX History

Year	Value	Change
2025	$3.93B	+3.2%
2024	$3.81B	+30.8%
2023	$2.91B	+4.8%
2022	$2.78B	-23.8%
2021	$3.65B	+27.1%
2020	$2.87B	+4.1%
2019	$2.76B	+15.2%
2018	$2.39B	-15.6%
2017	$2.84B	-10.4%
2016	$3.17B	+9.0%
2015	$2.90B	+0.7%
2014	$2.88B	+8.2%
2013	$2.66B	+10.6%
2012	$2.41B	+13.1%
2011	$2.13B	-15.6%
2010	$2.52B	-14.1%
2009	$2.94B	-22.8%
2008	$3.81B	-11.2%

Year	Value	Change
2007	$4.29B	+46.5%
2006	$2.93B	+36.4%
2005	$2.15B	+12.4%
2004	$1.91B	+10.1%
2003	$1.73B	-5.7%
2002	$1.84B	-2.5%
2001	$1.89B	+13.1%
2000	$1.67B	-17.1%
1999	$2.01B	+155.6%
1998	$787.20M	+15.8%
1997	$679.62M	+8.6%
1996	$625.63M	-42.0%
1995	$1.08B	+25.4%
1994	$860.88M	-12.0%
1993	$977.77M	-6.2%
1992	$1.04B	-12.1%
1991	$1.19B	-

FAQ

What is the current annual CAPEX of GSK?: As of today, GSK annual CAPEX is $3.93B
What is 1-year change in GSK annual CAPEX?: GSK annual CAPEX is up +3.24% year-over-year
What is 3-year change in GSK annual CAPEX?: GSK annual CAPEX is up +41.44% over the past 3 years
How far is GSK annual CAPEX from its all-time high?: GSK annual CAPEX is currently -8.27% below its historical high of $4.29B set on December 31, 2007
How does GSK annual CAPEX rank versus sector peers?: GSK annual CAPEX is higher than 99.38% of companies in Healthcare sector
When is GSK next annual earnings release?: The next annual earnings release for GSK is on February 3, 2027

Quarterly CAPEX

$719.73M$154.74M-17.70%

September 30, 2026

Summary

Current Value: As of today, GSK quarterly CAPEX is $719.73M, down -17.70% on September 30, 2026
Historical Performance: GSK quarterly CAPEX is down -40.24% year-over-year, up +12.23% over the past 3 years
All-Time High Comparison: GSK quarterly CAPEX is currently -56.95% below its historical high of $1.67B set on December 31, 2000
3-Year Low Comparison: GSK quarterly CAPEX is +29.39% above its 3-year low of $556.23M reached on June 30, 2024
Sector Comparison: GSK quarterly CAPEX is higher than 99.13% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly CAPEX	Sep 30, 26	$719.73M	-17.7%	-40.2%	+12.2%	-56.8%
Annual CAPEX	Dec 31, 25	$3.93B	–	+3.2%	+41.4%	+37.0%
TTM CAPEX	Sep 30, 26	$3.54B	-12.0%	-13.8%	+25.5%	-12.5%
Price	Nov 6, 26	$50.33	-3.5%	+6.9%	+44.7%	+13.5%
Quarterly Cash From Operations	Sep 30, 26	$3.77B	+11.5%	+24.5%	+35.8%	+7.7%
Quarterly Free Cash Flow	Sep 30, 26	$3.05B	+21.6%	+67.2%	+42.8%	+66.0%
Quarterly Cash From Investing	Sep 30, 26	-$10.48B	-790.8%	-386.8%	-1464.7%	-535.2%
Quarterly Total Assets	Sep 30, 26	$95.25B	+16.2%	+15.3%	+28.2%	-10.2%
Quarterly D&A	Sep 30, 26	$998.44M	+236.1%	-4.8%	+34.1%	-20.9%

Quarterly CAPEX Highs

GSK Quarterly CAPEX Highs Comparison
Period	High	Date	Current
1Y	$1.35B	Dec 31, 25	-46.6%
3Y	$1.51B	Dec 31, 24	-52.2%
5Y	$1.67B	N/A	-56.8%
All	$1.67B	Dec 31, 00	-57.0%

Quarterly CAPEX Lows

GSK Quarterly CAPEX Lows Comparison
Period	Low	Date	Current
1Y	$596.89M	Mar 31, 26	+20.6%
3Y	$556.23M	Jun 30, 24	+29.4%
5Y	$556.23M	Jun 30, 24	+29.4%
All	$139.20M	Jun 30, 00	+417.1%

Quarterly CAPEX History

Month	Value	Change
Sep 2026	$719.73M	-17.7%
Jun 2026	$874.46M	+46.5%
Mar 2026	$596.89M	-55.7%
Dec 2025	$1.35B	+11.9%
Sep 2025	$1.20B	+44.7%
Jun 2025	$832.32M	+47.5%
Mar 2025	$564.17M	-62.5%
Dec 2024	$1.51B	+40.4%
Sep 2024	$1.07B	+92.8%
Jun 2024	$556.23M	-22.1%
Mar 2024	$713.85M	-24.2%
Dec 2023	$942.34M	+46.9%
Sep 2023	$641.27M	-4.8%
Jun 2023	$673.41M	+4.8%
Mar 2023	$642.76M	-25.5%
Dec 2022	$862.89M	+54.0%
Sep 2022	$560.27M	-1.8%
Jun 2022	$570.40M	-25.4%
Mar 2022	$764.38M	+6.7%
Dec 2021	$716.38M	-57.0%
Sep 2021	$1.67B	+114.7%
Jun 2021	$775.59M	+58.9%
Mar 2021	$488.13M	-56.3%
Dec 2020	$1.12B	+37.4%
Sep 2020	$813.08M	+62.9%
Jun 2020	$499.22M	+13.6%
Mar 2020	$439.52M	-53.4%
Dec 2019	$942.39M	+66.2%
Sep 2019	$566.91M	-31.6%
Jun 2019	$828.52M	+109.3%
Mar 2019	$395.92M	-53.2%
Dec 2018	$846.28M	+53.7%
Sep 2018	$550.59M	+5.9%
Jun 2018	$519.90M	+5.2%
Mar 2018	$494.01M	-43.7%
Dec 2017	$877.67M	+33.8%
Sep 2017	$655.88M	-15.8%
Jun 2017	$778.57M	+51.0%
Mar 2017	$515.48M	-46.6%
Dec 2016	$965.55M	+49.5%
Sep 2016	$645.78M	-4.6%
Jun 2016	$677.08M	-22.8%
Mar 2016	$876.79M	-16.0%
Dec 2015	$1.04B	+53.3%
Sep 2015	$680.87M	+6.3%
Jun 2015	$640.37M	+16.1%
Mar 2015	$551.37M	-42.1%
Dec 2014	$951.74M	+36.0%
Sep 2014	$699.83M	+5.1%
Jun 2014	$665.94M	+14.8%
Mar 2014	$580.09M	-29.5%
Dec 2013	$823.11M	+18.0%
Sep 2013	$697.77M	+7.1%
Jun 2013	$651.60M	+32.5%

Month	Value	Change
Mar 2013	$491.62M	-41.5%
Dec 2012	$840.05M	+41.4%
Sep 2012	$594.30M	+3.3%
Jun 2012	$575.29M	+43.6%
Mar 2012	$400.63M	-45.9%
Dec 2011	$740.25M	+58.3%
Sep 2011	$467.54M	-6.4%
Jun 2011	$499.60M	+15.9%
Mar 2011	$431.00M	-38.5%
Dec 2010	$700.46M	-12.6%
Sep 2010	$801.57M	+100.2%
Jun 2010	$400.31M	+25.0%
Mar 2010	$320.28M	-68.6%
Dec 2009	$1.02B	+59.6%
Sep 2009	$638.83M	+6.0%
Jun 2009	$602.87M	+56.9%
Mar 2009	$384.17M	-70.7%
Dec 2008	$1.31B	+38.6%
Sep 2008	$946.01M	+38.3%
Jun 2008	$684.17M	+35.5%
Mar 2008	$505.01M	-59.9%
Dec 2007	$1.26B	+46.1%
Sep 2007	$861.84M	+7.7%
Jun 2007	$799.91M	-42.2%
Mar 2007	$1.38B	+60.2%
Dec 2006	$863.89M	+24.9%
Sep 2006	$691.45M	+28.8%
Jun 2006	$536.75M	+32.6%
Mar 2006	$404.81M	-34.7%
Dec 2005	$620.34M	+45.4%
Sep 2005	$426.61M	+18.6%
Jun 2005	$359.74M	+50.2%
Mar 2005	$239.46M	-53.1%
Dec 2004	$510.17M	+44.4%
Sep 2004	$353.19M	+3.1%
Jun 2004	$342.46M	+54.0%
Mar 2004	$222.39M	-59.4%
Dec 2003	$548.06M	+74.7%
Sep 2003	$313.70M	+5.1%
Jun 2003	$298.51M	+21.7%
Mar 2003	$245.22M	-61.3%
Dec 2002	$633.22M	+79.0%
Sep 2002	$353.72M	+6.5%
Jun 2002	$332.26M	+32.4%
Mar 2002	$250.99M	-61.0%
Dec 2001	$643.88M	+76.5%
Sep 2001	$364.76M	+17.7%
Jun 2001	$309.88M	+9.5%
Mar 2001	$282.93M	-83.1%
Dec 2000	$1.67B	+553.6%
Sep 2000	$255.77M	+83.7%
Jun 2000	$139.20M	-64.8%
Mar 2000	$394.97M	-

FAQ

What is the current quarterly CAPEX of GSK?: As of today, GSK quarterly CAPEX is $719.73M
What is GSK quarterly CAPEX most recent change?: GSK quarterly CAPEX was down -17.70% on September 30, 2026
What is 1-year change in GSK quarterly CAPEX?: GSK quarterly CAPEX is down -40.24% year-over-year
How far is GSK quarterly CAPEX from its all-time high?: GSK quarterly CAPEX is currently -56.95% below its historical high of $1.67B set on December 31, 2000
How does GSK quarterly CAPEX rank versus sector peers?: GSK quarterly CAPEX is higher than 99.13% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on February 3, 2027

TTM CAPEX

$3.54B$484.54M-12.04%

September 30, 2026

Summary

Current Value: As of today, GSK TTM CAPEX is $3.54B, down -12.04% on September 30, 2026
Historical Performance: GSK TTM CAPEX is down -13.81% year-over-year, up +25.49% over the past 3 years
All-Time High Comparison: GSK TTM CAPEX is currently -17.79% below its historical high of $4.31B set on December 31, 2007
3-Year Low Comparison: GSK TTM CAPEX is +25.49% above its 3-year low of $2.82B reached on an earlier date
Sector Comparison: GSK TTM CAPEX is higher than 99.42% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM CAPEX	Sep 30, 26	$3.54B	-12.0%	-13.8%	+25.5%	-12.5%
Annual CAPEX	Dec 31, 25	$3.93B	–	+3.2%	+41.4%	+37.0%
Quarterly CAPEX	Sep 30, 26	$719.73M	-17.7%	-40.2%	+12.2%	-56.8%
Price	Nov 6, 26	$50.33	-3.5%	+6.9%	+44.7%	+13.5%
TTM Cash From Operations	Sep 30, 26	$11.39B	+7.0%	+16.8%	+90.3%	+16.0%
TTM Free Cash Flow	Sep 30, 26	$7.85B	+18.5%	+39.0%	+148.0%	+36.0%
TTM Cash From Investing	Sep 30, 26	-$16.62B	-100.4%	-174.0%	-441.5%	-717.6%
Quarterly Total Assets	Sep 30, 26	$95.25B	+16.2%	+15.3%	+28.2%	-10.2%
TTM D&A	Sep 30, 26	$3.31B	-1.5%	-30.3%	+63.7%	-44.4%

TTM CAPEX Highs

GSK TTM CAPEX Highs Comparison
Period	High	Date	Current
1Y	$4.11B	N/A	-13.8%
3Y	$4.11B	Sep 30, 25	-13.8%
5Y	$4.11B	Sep 30, 25	-13.8%
All	$4.31B	Dec 31, 07	-17.8%

TTM CAPEX Lows

GSK TTM CAPEX Lows Comparison
Period	Low	Date	Current
1Y	$3.54B	Sep 30, 26	at low
3Y	$2.82B	N/A	+25.5%
5Y	$2.61B	Sep 30, 22	+35.5%
All	$394.97M	Mar 31, 00	+796.0%

TTM CAPEX History

Month	Value	Change
Sep 2026	$3.54B	-12.0%
Jun 2026	$4.02B	+1.1%
Mar 2026	$3.98B	+0.8%
Dec 2025	$3.95B	-3.8%
Sep 2025	$4.11B	+3.3%
Jun 2025	$3.97B	+7.5%
Mar 2025	$3.70B	-3.9%
Dec 2024	$3.85B	+17.1%
Sep 2024	$3.28B	+15.1%
Jun 2024	$2.85B	-3.9%
Mar 2024	$2.97B	+2.5%
Dec 2023	$2.90B	+2.8%
Sep 2023	$2.82B	+3.0%
Jun 2023	$2.74B	+3.9%
Mar 2023	$2.64B	-4.4%
Dec 2022	$2.76B	+5.6%
Sep 2022	$2.61B	-29.7%
Jun 2022	$3.72B	-5.2%
Mar 2022	$3.92B	+7.6%
Dec 2021	$3.65B	-9.9%
Sep 2021	$4.05B	+26.7%
Jun 2021	$3.19B	+9.5%
Mar 2021	$2.92B	+1.7%
Dec 2020	$2.87B	+6.5%
Sep 2020	$2.69B	+10.1%
Jun 2020	$2.45B	-11.9%
Mar 2020	$2.78B	+1.6%
Dec 2019	$2.73B	+3.6%
Sep 2019	$2.64B	+0.6%
Jun 2019	$2.62B	+13.3%
Mar 2019	$2.31B	-4.1%
Dec 2018	$2.41B	-1.3%
Sep 2018	$2.44B	-4.1%
Jun 2018	$2.55B	-9.2%
Mar 2018	$2.81B	-0.8%
Dec 2017	$2.83B	-3.0%
Sep 2017	$2.92B	+0.3%
Jun 2017	$2.91B	+3.6%
Mar 2017	$2.80B	-11.4%
Dec 2016	$3.17B	-2.4%
Sep 2016	$3.24B	-1.1%
Jun 2016	$3.28B	+1.1%
Mar 2016	$3.24B	+11.2%
Dec 2015	$2.92B	+3.3%
Sep 2015	$2.82B	-0.7%
Jun 2015	$2.84B	-0.9%
Mar 2015	$2.87B	-1.0%
Dec 2014	$2.90B	+4.6%
Sep 2014	$2.77B	+0.1%
Jun 2014	$2.77B	+0.5%
Mar 2014	$2.75B	+3.3%
Dec 2013	$2.66B	-0.6%
Sep 2013	$2.68B	+4.0%
Jun 2013	$2.58B	+3.1%

Month	Value	Change
Mar 2013	$2.50B	+3.8%
Dec 2012	$2.41B	+4.3%
Sep 2012	$2.31B	+5.8%
Jun 2012	$2.18B	+3.6%
Mar 2012	$2.11B	-1.4%
Dec 2011	$2.14B	+1.9%
Sep 2011	$2.10B	-13.7%
Jun 2011	$2.43B	+4.3%
Mar 2011	$2.33B	+5.0%
Dec 2010	$2.22B	-12.6%
Sep 2010	$2.54B	+6.8%
Jun 2010	$2.38B	-7.8%
Mar 2010	$2.58B	-2.4%
Dec 2009	$2.65B	-9.9%
Sep 2009	$2.94B	-9.5%
Jun 2009	$3.24B	-2.4%
Mar 2009	$3.33B	-3.5%
Dec 2008	$3.45B	+1.5%
Sep 2008	$3.39B	+2.5%
Jun 2008	$3.31B	-3.4%
Mar 2008	$3.43B	-20.4%
Dec 2007	$4.31B	+10.1%
Sep 2007	$3.91B	+4.6%
Jun 2007	$3.74B	+7.6%
Mar 2007	$3.48B	+39.2%
Dec 2006	$2.50B	+10.8%
Sep 2006	$2.25B	+13.3%
Jun 2006	$1.99B	+9.8%
Mar 2006	$1.81B	+10.0%
Dec 2005	$1.65B	+7.2%
Sep 2005	$1.54B	+5.0%
Jun 2005	$1.46B	+1.2%
Mar 2005	$1.45B	+1.2%
Dec 2004	$1.43B	-2.6%
Sep 2004	$1.47B	+2.8%
Jun 2004	$1.43B	+3.2%
Mar 2004	$1.38B	-1.6%
Dec 2003	$1.41B	-5.7%
Sep 2003	$1.49B	-2.6%
Jun 2003	$1.53B	-2.2%
Mar 2003	$1.56B	-0.4%
Dec 2002	$1.57B	-0.7%
Sep 2002	$1.58B	-0.7%
Jun 2002	$1.59B	+1.4%
Mar 2002	$1.57B	-2.0%
Dec 2001	$1.60B	-39.1%
Sep 2001	$2.63B	+4.3%
Jun 2001	$2.52B	+7.3%
Mar 2001	$2.35B	-4.6%
Dec 2000	$2.46B	+211.6%
Sep 2000	$789.94M	+47.9%
Jun 2000	$534.17M	+35.2%
Mar 2000	$394.97M	-

FAQ

What is the current TTM CAPEX of GSK?: As of today, GSK TTM CAPEX is $3.54B
What is GSK TTM CAPEX most recent change?: GSK TTM CAPEX was down -12.04% on September 30, 2026
What is 1-year change in GSK TTM CAPEX?: GSK TTM CAPEX is down -13.81% year-over-year
How far is GSK TTM CAPEX from its all-time high?: GSK TTM CAPEX is currently -17.79% below its historical high of $4.31B set on December 31, 2007
How does GSK TTM CAPEX rank versus sector peers?: GSK TTM CAPEX is higher than 99.42% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on February 3, 2027

Data Sources & References

GSK Official Website www.gsk.com
GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk